跨瘤类型的葡萄糖类-1受体的表达和功能多样性
Mario M Alba1,2, Wilson H Lee1, Jerry S H Lee3,4,5,6
1Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy, University of Southern California, Los Angeles, CA, USA.
类似葡萄糖-1受体 (GLP-1R) 的表达因癌症类型而异,影响患者的治疗结果. 虽然GLP-1R突变很少见,但它的表达可能会影响瘤的行为,这需要进一步的瘤学研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 葡萄糖类-1受体 (GLP-1R) 激动剂已成为2型糖尿病 (T2DM) 和肥胖的治疗方法.
- 新出现的证据表明GLP-1R信号与癌症发展或进展之间存在潜在的联系.
- GLP-1R在瘤生物学中的确切作用仍然不完全理解.
研究的目的:
- 为了研究GLP-1R在各种人类癌症类型中的表达模式.
- 确定GLP-1R表达在不同癌症中的预后意义.
- 分析瘤内GLP-1R基因的基因变异的频率和类型.
主要方法:
- 利用来自癌症基因组图谱 (TCGA),基因型组织表达 (GTEx) 和人类蛋白质图谱的大型基因组数据集.
- 将瘤组织中的GLP-1RmRNA表达水平与相邻的正常组织进行比较.
- 使用cBioPortal进行了生存分析 (整体和无疾病) 并评估了GLP-1R遗传变异.
主要成果:
- GLP-1R表达在癌症类型中表现出显著的异质性,在乳腺,肺癌和结肠癌中较低,但在食道,脏和甲状腺瘤中较高.
- 增加GLP-1R表达与改善低度质瘤的存活率相关,但肺状细胞癌的结果较差.
- GLP-1R的遗传变化很少发生,尤其是食道和卵巢癌中观察到放大.
结论:
- GLP-1R表现出组织特异性表达,并且在各种癌症类型中具有预后价值.
- GLP-1R基因变化的低发病率表明突变在癌症进展中的直接作用有限.
- 可变的GLP-1R表达可能会影响瘤行为,需要进一步研究其功能作用和GLP-1Ragonists在瘤学中的治疗潜力.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
相关概念视频
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: The Receptor and Signaling Pathways
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
